Tag: Doses
News
Vaxxas Secures U.S. Patent for HD-MAP Vaccine Technology
Vaxxas, a clinical-stage biotech firm has obtained a new patent from the United States patent office covering proprietary manufacturing technology for its revolutionary immunisation...
News
In Developing Nations, mRNA Boosters Can Be Great Investment
Because of their inexpensive cost, vaccinations made with inactivated SARS-CoV-2 viruses are widely used in underdeveloped countries. As per new research from Sweden's Karolinska...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read